translation agency

Business Wire
Ardea Biosciences Reports Recent Accomplishments and First

May 8, 2009
Restructuring to Focus Company on Clinical - Stage Programs

SAN DIEGO - Ardea Biosciences, Inc. (Nasdaq: RDEA), a biotechnology company focused on the development of small - molecule therapeutics for the treatment of gout, human immunodeficiency virus (HIV), cancer and inflammatory diseases, today reported recent accomplishments and financial results for the first quarter ended March 31, 2009 and announced a restructuring of operations. The restructuring is intended to conserve financial resources by focusing the Company on its clinical - stage programs.